nbc news semaglutide Popular diabetes and weight loss drugs often hard to get for people who need them Weight loss drug shortages prompt

In TRIUMPH-1, the first large Phase 3 trial (a large human trial with thousands of participants) in adults with obesity, retatrutide produced an average weight loss of 28.3% at the 12 mg dose after 80 weeks

The AG competes on price, which drives down margins for the first-filer, reducing the profitability that makes Paragraph IV challenges attractive in the first place

If your symptoms began after starting Ozempic or Wegovy, and you werent warned about the risks, you may have a valid case

Alcohol-induced gut microbial reorganization and associated overproduction of phenylacetylglutamine promotes cardiovascular disease